How mild head injuries might trigger tau changes linked to Alzheimer’s
Using a novel mTBI model to investigate phosphorylation dependent common mechanisms in tauopathies
['FUNDING_R01'] · UNIVERSITY OF MINNESOTA · NIH-11285289
Looking at whether mild traumatic brain injury causes chemical changes in tau protein that can lead to Alzheimer’s and related dementias.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11285289 on ClinicalTrials.gov |
What this research studies
Researchers will use a new mouse model that mimics mild traumatic brain injury to see if that injury causes specific phosphorylation (chemical) changes in tau protein, makes tau move to the wrong part of nerve cells, and leads to synaptic problems. The team will measure tau phosphorylation at particular residues, use biochemical and imaging tests, and examine behavior and brain pathology in mice. They will also test whether blocking those early phosphorylation events prevents tau buildup and related signaling defects. The goal is to refine a mechanism that links head injury to tau-driven disease and point toward targets for future treatments.
Who could benefit from this research
Good fit: This is preclinical lab research and does not enroll patients, but people with past mild head injury or early-stage Alzheimer’s would be the most relevant candidates for future clinical work based on these results.
Not a fit: Patients whose cognitive problems are due to non-tau causes (for example primarily vascular dementia) are unlikely to benefit directly from findings targeting tau phosphorylation.
Why it matters
Potential benefit: If successful, this work could identify early molecular targets to prevent tau pathology and lead to new treatments that slow or stop Alzheimer’s progression.
How similar studies have performed: Prior cell-culture work supports the idea that specific tau phosphorylation is an early event, but translating those findings in animal models and to humans remains novel and not yet proven.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIAO, DEZHI — UNIVERSITY OF MINNESOTA
- Study coordinator: LIAO, DEZHI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease